Image of Non-Biological Complex Drugs:The Science and the Regulatory Landscape
Bookmark Share

Text

Non-Biological Complex Drugs:The Science and the Regulatory Landscape

The rise of bio- and nano-technology in the last decades has led to the emergence of a new and unique type of medicine known as non-biological complex drugs (NBCDs). This book illustrates the challenges associated with NBCD development, as well as the complexity of assessing the effects of manufacturing changes on innovator and follow-on batches of NBCDs. It also touches upon proven marketing authorization requirements for biosimilars that could be effective in evaluating follow-on NBCDs, including a demonstration of control over the manufacturing process and a need for detailed physico-chemical characterization and (pre)clinical tests.This book is meant to be used for years to come as a standard reference work for the development of NBCDs. Moreover, this book aims to stimulate discussions and further our thinking to ensure that decisions regarding the approval of complex drugs are made with relevant scientific data on the table.

Availability

No copy data

Detail Information
Series Title
AAPS Advances in the Pharmaceutical Sciences Series
Call Number
-
Publisher
Switzerland : Springer Cham.,
Collation
IX, 390
Language
English
ISBN/ISSN
978-3-319-16240-9
Classification
NONE
Content Type
text
Media Type
computer
Carrier Type
online resource
Edition
1
Subject(s)
Pharmaceutics
Specific Detail Info
-
Statement of Responsibility
Other Information
Cataloger
Devi
Source
https://oer.unej.ac.id/index.php?p=show_detail&id=11773
Validator
TAUFIK
Other version/related

No other version available

File Attachment
Comments
You must be logged in to post a comment